Cubist Systematic Strategies’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-446,764
| Closed | -$5.92M | – | 3508 |
|
|
2024
Q4 | $5.92M | Buy |
+446,764
| New | +$6.14M | 0.04% | 733 |
|
|
2024
Q2 | – | Sell |
-68
| Closed | -$945 | – | 3977 |
|
|
2024
Q1 | $945 | Buy |
+68
| New | +$989 | ﹤0.01% | 3600 |
|
|
2023
Q3 | – | Sell |
-58
| Closed | -$911 | – | 3890 |
|
|
2023
Q2 | $911 | Sell |
58
-89,642
| -100% | -$1.47M | ﹤0.01% | 3369 |
|
|
2023
Q1 | $1.48M | Buy |
89,700
+27,511
| +44% | +$438K | 0.01% | 1883 |
|
|
2022
Q4 | $970K | Buy |
62,189
+32,757
| +111% | +$458K | 0.01% | 2477 |
|
|
2022
Q3 | $382K | Sell |
29,432
-83,010
| -74% | -$1.15M | ﹤0.01% | 3361 |
|
|
2022
Q2 | $1.58M | Buy |
112,442
+50,701
| +82% | +$724K | 0.01% | 2072 |
|
|
2022
Q1 | $884K | Sell |
61,741
-98,995
| -62% | -$1.45M | 0.01% | 2131 |
|
|
2021
Q4 | $2.19M | Buy |
160,736
+122,032
| +315% | +$1.71M | 0.02% | 1284 |
|
|
2021
Q3 | $634K | Sell |
38,704
-23,886
| -38% | -$401K | 0.01% | 1862 |
|
|
2021
Q2 | $1.05M | Sell |
62,590
-80,657
| -56% | -$1.37M | 0.01% | 1539 |
|
|
2021
Q1 | $2.62M | Buy |
143,247
+96,771
| +208% | +$1.74M | 0.03% | 856 |
|
|
2020
Q4 | $846K | Sell |
46,476
-13,902
| -23% | -$244K | 0.01% | 1483 |
|
|
2020
Q3 | $1.08M | Sell |
60,378
-26,176
| -30% | -$477K | 0.02% | 1292 |
|
|
2020
Q2 | $1.55M | Buy |
86,554
+53,695
| +163% | +$964K | 0.03% | 940 |
|
|
2020
Q1 | $499K | Sell |
32,859
-8,148
| -20% | -$148K | 0.01% | 1262 |
|
|
2019
Q4 | $809K | Buy |
41,007
+34,220
| +504% | +$655K | 0.01% | 1293 |
|
|
2019
Q3 | $117K | Sell |
6,787
-40,274
| -86% | -$697K | ﹤0.01% | 1904 |
|
|
2019
Q2 | $833K | Sell |
47,061
-5,423
| -10% | -$98.7K | 0.02% | 1145 |
|
|
2019
Q1 | $1.07M | Buy |
+52,484
| New | +$1.06M | 0.03% | 729 |
|
Other funds holding TAK
BIP
